Revvity | PKI - Des Atouts





Des Atouts Changement Date
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Bio Techne USD 2.55B 27.9M 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Celltrion KRW 759.44B 20.32T 2025-12
Charles River Laboratories USD 7.73B 594.89M 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.23B 200M 2026-03
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Illumina USD 6.56B 85M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Laboratory Of America USD 19.09B 694.4M 2026-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.67B 43.73M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
OraSure Technologies USD 379.17M 24M 2026-03
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Pharma Mar EUR 385.26M 9.82M 2026-03
Qiagen NV USD 6.3B 257.54M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Repligen USD 2.93B 18.93M 2026-03
Revvity USD 12B 171.82M 2026-03
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Tilray USD 2.1B 15.95M 2025-09
Waters USD 24.53B 19.45B 2026-03
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03